Chemotherapy News and Research

Latest Chemotherapy News and Research

UCLA study questions value of BRCA genetic testing in general population

Women who are carriers of mutated BRCA genes are known to have a significantly higher risk for developing breast and ovarian cancers than those who don't have the mutations.

4 Sep 2015

Acupuncture may be viable treatment for women experiencing hot flashes

Acupuncture may be a viable treatment for women experiencing hot flashes as a result of estrogen-targeting therapies to treat breast cancer, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania. Hot flashes are particularly severe and frequent in breast cancer survivors, but current FDA-approved remedies for these unpleasant episodes, such as hormone replacement therapies are off-limits to breast cancer survivors because they include estrogen.

4 Sep 2015

HBV DNA levels guide antiviral treatment in chemotherapy setting

Pretreatment levels of hepatitis B virus DNA could inform the withdrawal of pre-emptive antiviral therapy in chronic HBV patients undergoing cytotoxic chemotherapy for cancer, indicate research findings published in Digestive Diseases and Sciences.

3 Sep 2015

Acupuncture: A viable treatment for breast cancer survivors experiencing hot flashes

3 Sep 2015

HUYA Bioscience International expands HBI-8000 clinical trials for breast cancer

HUYA Bioscience International (HUYA) today announced expanding clinical trials with its lead cancer drug, HBI-8000, starting with a Phase 1 combination trial in support of a breast cancer program to be conducted in the United States.

3 Sep 2015

Children's Hospital Los Angeles receives $2 million to spur research on brain, spinal cord tumors

A life-changing event for a Los Angeles family has resulted in their funding an endowment to support The Kort Family Foundation Brain and Spinal Cord Tumor Research Program in the Division of Neurosurgery at Children's Hospital Los Angeles.

3 Sep 2015

Adaptimmune doses first patient in expanded Phase I/II trial of T-cell therapy for synovial sarcoma

Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in synovial sarcoma patients.

3 Sep 2015

Study reveals presence of new genetic mutation in melanoma cancer cells

There is strong evidence that the protein complex APC/C may function as a tumor suppressor in multiple cancers including lymphoma, colorectal and breast cancer, and now melanoma. A new study has revealed that a genetic mutation leading to repression of a specific protein, Cdh1, which interacts with APC/C, is present in melanoma cancer cells.

3 Sep 2015

UCLA scientists develop promising new combination treatment for glioblastoma

UCLA scientists have developed a potentially promising new combination therapy for glioblastoma, the deadliest form of brain cancer.

2 Sep 2015

Altering protein recycling complexes in human cells may help overcome chemotherapy resistance

Altering the protein recycling complexes in human cells, including cancer cells, allows the cells to resist treatment with a class of drugs known as proteasome inhibitors, according to Whitehead Institute scientists.

2 Sep 2015

Mayo Clinic study identifies benchmarks for postsurgical outcomes in patients with colorectal cancer

About 20 percent of colorectal cancer patients have cancers that have spread (metastasized) beyond the colon at the time of their diagnosis. The liver is the most common site for these metastases. The approach to treating primary tumors within the colon and metastatic tumors in the liver continues to evolve; however, it typically involves chemotherapy plus surgical removal (resection) of both types of tumors. However, experts continue to debate whether surgical resection of primary tumors and metastatic tumors should be performed at the same time (synchronously) or in separate operations (sequentially).

1 Sep 2015

Bionomics submission of BNC101 IND for cancer treatment passes FDA review

Bionomics Limited, a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, today announced that its BNC101 IND submission has passed review by the US Food and Drug Administration (FDA).

31 Aug 2015

Regen BioPharma develops novel means of delivering RGBP-248 gene silencing nucleic acid to liver tumors

Regen BioPharma, Inc. announced today development of a novel means of delivering its patented (US Patent 8,263,571) gene silencing nucleic acid, RGBP-248, to liver tumors utilizing a clinically approved formulation as delivery system. The product in development overcomes previous hurdles with gene silencing therapeutics in which the gene silencing drug had to be delivered throughout the whole body.

31 Aug 2015

Soligenix completes enrolment in SGX942 Phase 2 trial for oral mucositis in cancer patients

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today it has completed enrollment of the additional subjects, as directed by the Data Review Committee (DRC) earlier this year, into the company's Phase 2 study for SGX942.

31 Aug 2015

Brain tumor is not always the death sentence

Only half of brain cancers actually start in the brain. The rest - as in the case of former president Jimmy Carter - are metastatic tumors from cancer that originated elsewhere in the body.

29 Aug 2015

University of Huddersfield researchers develop new device to improve quality of care for young cancer patients

A DEVICE, developed through a collaboration by a team at the University of Huddersfield and a local charity, is set to improve the quality of care for child cancer patients. Medical practitioners and a dedicated charity have signalled that they are highly impressed by the design for a special harness, that safely and comfortably, contains the tubing inserted into the chests of youngsters during treatment.

29 Aug 2015

Researchers examine how patients handle stigma of using medical marijuana

Research recently published in Journal of Psychoactive Drugs (Routledge) examines the experiences of California residents who have been prescribed medical marijuana and the stigma they experience from public opinion. The findings indicate that the stigma of using medical marijuana may contribute to the under-treatment of those who might benefit from medical marijuana.

29 Aug 2015

Keratin 17 protein plays crucial role in degrading key tumor suppressor protein

Keratin 17 (K17), a protein previously believed to provide only mechanical support for cancer cells, appears to play a crucial role in degrading a key tumor suppressor protein in cancer cells named p27. This finding, published in the September 1 issue of Cancer Research, is based on the work of researchers in the Department of Pathology at Stony Brook University School of Medicine.

29 Aug 2015

New study may lead to effective treatment to prevent common chemotherapy side effects in cancer patients

Annually, hundreds of thousands of patients battling cancer undergo chemotherapy, which often results in poorly tolerated side effects such as nausea, vomiting, and loss of the desire to eat.

28 Aug 2015

Genetic test that predicts recurrence of breast cancer may impact use of chemotherapy

A genetic test that helps predict whether some women's breast cancer will recur might influence how chemotherapy is used, according to a study from Duke Medicine.

28 Aug 2015

Chemotherapy News and Research

Latest Chemotherapy News and Research

UCLA study questions value of BRCA genetic testing in general population

Acupuncture may be viable treatment for women experiencing hot flashes

HBV DNA levels guide antiviral treatment in chemotherapy setting

Acupuncture: A viable treatment for breast cancer survivors experiencing hot flashes

HUYA Bioscience International expands HBI-8000 clinical trials for breast cancer

Children's Hospital Los Angeles receives $2 million to spur research on brain, spinal cord tumors

Adaptimmune doses first patient in expanded Phase I/II trial of T-cell therapy for synovial sarcoma

Study reveals presence of new genetic mutation in melanoma cancer cells

UCLA scientists develop promising new combination treatment for glioblastoma

Altering protein recycling complexes in human cells may help overcome chemotherapy resistance

Mayo Clinic study identifies benchmarks for postsurgical outcomes in patients with colorectal cancer

Bionomics submission of BNC101 IND for cancer treatment passes FDA review

Regen BioPharma develops novel means of delivering RGBP-248 gene silencing nucleic acid to liver tumors

Soligenix completes enrolment in SGX942 Phase 2 trial for oral mucositis in cancer patients

Brain tumor is not always the death sentence

University of Huddersfield researchers develop new device to improve quality of care for young cancer patients

Researchers examine how patients handle stigma of using medical marijuana

Keratin 17 protein plays crucial role in degrading key tumor suppressor protein

New study may lead to effective treatment to prevent common chemotherapy side effects in cancer patients

Genetic test that predicts recurrence of breast cancer may impact use of chemotherapy

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in